ARCHIVES

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

December 29, 2006

Steven Woolf: Why CMS Should Not Cover LDCT

May 9, 2014

A Conversation With Daniel Masys: Acronym “CABIG” Could Be Eliminated

January 6, 2012

In Brief: Columbia-Presbyterian Cancer center to Be Renamed After Donor Herbert Irving

December 6, 1996

In Brief: Comprehensive Designation To MN Center; Bernardin Center Wins NCI Planning Grant

October 16, 1998

Ohio State to study center expansion.

September 26, 2003